Clinical Trial Update: 5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients [NA]

View source ↗

Summary

A clinical trial is evaluating 5-Methyltetrahydrofolate (5-MTHF) supplementation as a potential treatment for Type 1 diabetes. The study is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• 5-Methyltetrahydrofolate (5-MTHF) supplementation (levomefolic acid)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Type 1 Diabetes Mellitus | NA | Status: NOT_YET_RECRUITING